age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
84.13995
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 0
| 51,665
| 23,915.7656
| 28,919.6875
| 65
|
white
| 48
| 68
| 0.084
| 0.031998
| 3
| 0
| 0
|
no
| 0.25
| 0.25
|
no dnr
| 6
| 70
| 2.5
| 108
| 15
| 36.69531
| null | 2
| 0.899902
| 0.399963
| 137
| null | 155
| 11
| 3,000
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
41.314
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 0
| 10,240
| 5,688.7188
| 5,839.58984
| 9.5
|
white
| 24.398438
| 23
| 0.881958
| 0.802979
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 10
| 77
| 5.699219
| 60
| 20
| 36.09375
| null | 3.899902
| 0.599976
| 2.799805
| 139
| null | 115
| 70
| 1,200
| 2
| null | null | 1.838867
| 397
| 1
|
68.81598
|
male
| 1
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 16
|
$25-$50k
| 0
| 22,629
| 12,613.125
| 11,510.2734
| 16.333328
|
white
| 26.898438
| 39
| 0.75293
| 0.608887
| 1
| 1
| 0
|
no
| 0.9
| 0.7
|
dnr after sadm
| 14
| 72
| 18.398438
| 68
| 16
| 35.89844
| null | 1.699951
| null | 0.699951
| 137
| null | 68
| 15
| 310
| 2
| 3
|
<2 mo. follow-up
| 3
| 16
| 1
|
53.46997
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
under $11k
| 0
| 23,618
| 10,149.8594
| 15,127.375
| 19
|
white
| 31.296875
| 41
| 0.73291
| 0.649902
| 1
| 1
| 0
|
no
| 0.35
| 0.27
|
no dnr
| 12
| 77
| 5.699219
| 60
| 20
| 35.59375
| 548
| 3.399902
| 0.299988
| 2.899902
| 136
| 7.299805
| 54
| 63
| 780
| 1
| 0
|
SIP>=30
| 0
| 941
| 0
|
57.35498
|
male
| 0
| 16
|
Lung Cancer
|
Cancer
| 2
| 10
|
under $11k
| 0
| 27,340
| 14,559.7422
| 18,433.9688
| 15.666664
|
white
| 28.898438
| 23
| 0.431946
| 0.125
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
dnr after sadm
| 1
| 77
| 8.199219
| 70
| 25
| 36.09375
| null | null | 0.399963
| 0.699951
| 132
| null | 94
| 10
| 1,550
| 3
| 1
|
<2 mo. follow-up
| 1
| 44
| 1
|
79.15094
|
female
| 0
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
| null | 9
| 53,562
| null | null | 19.25
|
white
| 23.398438
| 30
| 0.657959
| 0.55896
| 2
| 1
| 1
|
yes
| 0.3
| 0.3
|
dnr after sadm
| 5
| 123
| 12.5
| 67
| 25
| 36.09375
| 170
| null | null | 1.899902
| 138
| 7.449219
| 92
| 27
| 2,170
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 102
| 1
|
77.133
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 7,707
| 3,549.8262
| 3,900.88867
| 14
|
white
| 12.699219
| 14
| 0.896973
| 0.860962
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 6
| 103
| 10.5
| 44
| 6
| 37.89844
| 214
| null | 0.5
| 2.699707
| 145
| 7.399414
| 440
| 81
| 615
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 939
| 0
|
63.72299
|
male
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 9
|
under $11k
| 0
| 12,741
| 6,802.207
| 6,108.97656
| 17.5
|
white
| 26.5
| 55
| 0.640991
| 0.459961
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
dnr after sadm
| 4
| 107
| 12
| 80
| 25
| 35.59375
| null | null | null | 1.099854
| 136
| null | 181
| 18
| 5,800
| 0
| 0
|
<2 mo. follow-up
| 0
| 52
| 1
|
72.30896
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
$11-$25k
| 0
| 32,851
| 14,498.5859
| 23,926.0781
| 13
|
white
| 25.296875
| 31
| 0.660889
| 0.563965
| 4
| 0
| 0
|
yes
| 0.75
| 0.5
|
no dnr
| 7
| 77
| 11.199219
| 80
| 20
| 36.09375
| 476.1875
| 2.5
| 0.599976
| 4.199219
| 147
| 7.40918
| 77
| 107
| 400
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 939
| 0
|
56.20798
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 58,257
| 36,612.6875
| 36,632.8125
| 19.333328
|
white
| 25.699219
| 31
| 0.723999
| 0.638916
| 5
| 0
| 0
|
yes
| 0.6
| 0.5
|
no dnr
| 19
| 49
| 18.796875
| 120
| 44
| 36.39844
| 173.46875
| 3.599609
| null | 1.899902
| 135
| 7.429688
| 92
| 46
| 1,520
| null | null | null | 2.831543
| 939
| 0
|
90.448
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 9
| 23,279
| 14,248.1094
| 14,757.8672
| 23
|
white
| 24.5
| 23
| 0.659912
| 0.562988
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 11
| 77
| 12.398438
| 120
| 25
| 38.59375
| 368
| null | 0.699951
| 1
| 136
| 7.419922
| 103
| 11
| 850
| null | 1
|
no(M2 and SIP pres)
| 1
| 872
| 1
|
68.08795
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 24,806
| 12,282.0547
| 14,048.6953
| 14.666664
| null | 23.699219
| 16
| 0.800903
| 0.735962
| 1
| 1
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 14
| 55
| 12
| 98
| 10
| 36.09375
| 78.75
| 2.899902
| 1.299805
| 7.699219
| 135
| 7.349609
| 163
| 50
| 3,800
| null | null | null | 2.783203
| 938
| 0
|
79.51495
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 7
|
$11-$25k
| 44
| 38,930
| 17,790.625
| 24,372.1875
| 44
|
white
| 25.699219
| 39
| 0.344971
| 0.228973
| 13
| 0
| 0
|
yes
| 0.1
| 0.05
|
dnr after sadm
| 4
| 77
| 5.599609
| 70
| 35
| 38
| 204
| null | null | 0.699951
| 131
| 7.399414
| 168
| 19
| 948
| null | null |
<2 mo. follow-up
| 3.268555
| 5
| 1
|
42.62299
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 13
| null | 0
| 7,367
| 4,045.7656
| 4,036.28906
| 11
|
white
| 14
| 11
| 0.803955
| 0.581909
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.8
|
no dnr
| 6
| 57
| 19.796875
| 70
| 20
| 36.09375
| 433.3125
| 2.199707
| 0.5
| 1.399902
| 142
| 7.479492
| 93
| 41
| null | 2
| 3
| null | 3
| 937
| 0
|
83.99695
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 7
|
under $11k
| 0
| 7,790
| 4,020.8164
| 4,064.10938
| 14
|
white
| 21.796875
| 29
| 0.715942
| 0.557983
| 1
| 1
| 0
|
yes
| null | null |
no dnr
| 6
| 47
| 21
| 134
| 10
| 34.79688
| 62
| 2
| 0.199982
| 2.299805
| 136
| 7.399414
| 165
| 34
| 2,948
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 937
| 0
|
33.89697
|
male
| 0
| 24
|
Coma
|
Coma
| 1
| null | null | 0
| 46,364
| 30,283.7969
| 29,555.2969
| 30.666656
|
white
| 19.699219
| 19
| 0.895996
| 0.875
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 24
| 47
| 8.599609
| 100
| 20
| 36.09375
| null | 4
| 1.599854
| 0.799927
| 135
| 7.439453
| 107
| 15
| 1,100
| null | null | null | 1.926514
| 936
| 0
|
71.51495
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 18,491
| 8,120.4453
| 14,476.6094
| 14.5
|
white
| 21.898438
| 77
| 0.791992
| 0.723999
| 3
| 0
| 0
|
no
| 0.75
| 0.3
|
dnr after sadm
| 1
| 77
| 9.298828
| 80
| 25
| 36.69531
| null | 2.799805
| 3.699707
| 1.199951
| 127
| null | 197
| 28
| 800
| null | 2
|
<2 mo. follow-up
| 2
| 7
| 1
|
82.87994
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 8,872
| 4,778.4258
| 4,944.73828
| 14.5
|
white
| 19.097656
| 39
| 0.776978
| 0.644897
| 1
| 0
| 0
|
no
| 0.9
| 0.6
|
dnr after sadm
| 1
| 103
| 6.199219
| 49
| 24
| 38.39844
| 152.5
| 3.099609
| 9.199219
| 0.5
| 149
| 7.399414
| 331
| 15
| 1,260
| null | null |
no(M2 and SIP pres)
| 3.818848
| 225
| 1
|
31.806
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 21,303
| 8,634.6562
| 12,423.125
| 16
|
black
| 27.699219
| 39
| 0.858887
| 0.809937
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 13
| 71
| 11.5
| 84
| 16
| 38.39844
| null | 2.399902
| 0.299988
| 0.699951
| 131
| null | 134
| 9
| 1,800
| 1
| 0
| null | 0
| 929
| 0
|
83.995
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 4,725
| 2,720.9766
| 2,598.51953
| 7
|
white
| 18.097656
| 33
| 0.822998
| 0.711914
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 60
| 23
| 60
| 30
| 38.19531
| 178.3125
| 2.099609
| null | 1
| 129
| 7.449219
| 276
| 17
| 2,495
| null | 1
|
no(M2 and SIP pres)
| 1
| 929
| 0
|
43.64398
|
male
| 1
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 61,249
| 20,110.8438
| 41,584.375
| 40.333313
|
white
| 31.796875
| 30
| 0.651978
| 0.473999
| 3
| 0
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 14
| 100
| 6.799805
| 80
| 20
| 37.19531
| 478.3125
| 3.299805
| 0.199982
| 1.099854
| 137
| 7.419922
| 189
| 19
| 1,150
| null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
54.103
|
male
| 0
| 66
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 149,841
| 64,629.4375
| 104,043.75
| 23
|
white
| 28.898438
| 40
| 0.707886
| 0.618896
| 11
| 0
| 0
|
no
| 0.3
| 0.3
|
no dnr
| 66
| 63
| 13.5
| 70
| 20
| 36.59375
| null | 1.799805
| 6.5
| 2.799805
| 137
| null | 132
| 82
| 980
| 2
| 1
|
SIP>=30
| 1
| 928
| 0
|
60.40799
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 11
|
$25-$50k
| 0
| 3,982
| 2,106.6113
| 1,150.20996
| null |
white
| 19.796875
| 22
| 0.875977
| 0.793945
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 3
| 62
| 9.798828
| 55
| 28
| 36.39844
| 121.65625
| 2.899902
| null | 1.199951
| 137
| 7.469727
| 123
| 25
| 1,905
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 342
| 1
|
83.56195
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 37,685
| 18,763.4062
| 20,545.7031
| 12.5
|
white
| 20.699219
| 22
| 0.701904
| 0.612915
| 4
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 8
| 63
| 10.298828
| 97
| 28
| 38.29688
| 136.71875
| null | null | 0.399963
| 136
| 7.469727
| 88
| 12
| 920
| 2
| 2
|
no(M2 and SIP pres)
| 2
| 926
| 0
|
82.35999
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 24
|
>$50k
| 0
| 56,254
| 30,071.8281
| 38,469.7812
| 22.5
|
white
| 29
| 25
| 0.541992
| 0.427979
| 13
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 10
| 110
| 14.798828
| 67
| 24
| 36.09375
| 173.3125
| 4.099609
| 0.599976
| 1.899902
| 135
| 7.369141
| 88
| 35
| 2,380
| null | 0
|
no(M2 and SIP pres)
| 0
| 925
| 0
|
61.90598
|
male
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
|
$11-$25k
| 0
| 43,792
| 18,118.8438
| 21,882
| 14.75
|
white
| 23.398438
| 57
| 0.824951
| 0.765991
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 26
| 81
| 7.099609
| 116
| 24
| 38
| 144.875
| null | null | 0.799927
| 134
| 7.479492
| 185
| 7
| 1,850
| 1
| 1
|
<2 mo. follow-up
| 1
| 28
| 1
|
54.784
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 15,991
| 7,817.5508
| 3,487.22852
| 13
|
white
| 2
| 16
| 0.911987
| 0.795898
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 4
| 113
| 15.5
| 126
| 38
| 36.29688
| 230
| 2
| null | 0.599976
| 142
| 7.429688
| 231
| 7
| 1,421
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 922
| 0
|
74.85297
|
male
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$11-$25k
| 100
| 44,102
| 15,078.0781
| 27,142.5781
| 10
|
white
| 44.796875
| 84
| 0.001
| 0
| 7
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 77
| 8.099609
| 76
| 18
| 36.79688
| null | 3.399902
| 0.399963
| 1
| 142
| null | 100
| 7
| 3,250
| null | null |
<2 mo. follow-up
| 4.283203
| 3
| 1
|
73.18799
|
female
| 0
| 28
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 0
| 45,490
| 24,600.6406
| 25,142.2188
| 8.75
|
white
| 20.097656
| 52
| 0.834961
| 0.72998
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 28
| 77
| 7.099609
| 50
| 25
| 36.09375
| 261.875
| null | 0.899902
| 1.599854
| 145
| 7.439453
| 114
| 25
| null | 1
| 5
|
SIP>=30
| 5
| 753
| 1
|
54.16599
|
female
| 0
| 75
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 193,965
| 73,248.25
| 128,066.688
| 38.5
|
white
| 25.796875
| 43
| 0.817993
| 0.756958
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 75
| 77
| 14.099609
| 108
| 22
| 38.69531
| 212.5
| 2.899902
| 1.899902
| 0.899902
| 142
| 7.419922
| 100
| 27
| 1,875
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 919
| 0
|
81.97095
|
male
| 0
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 3
| null | 0
| 141,760
| 122,821.688
| 120,521.125
| 24.75
|
white
| 19.699219
| 51
| 0.747925
| 0.667969
| 17
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 41
| 131
| 18
| 66
| 4
| 38.39844
| 379
| 3.099609
| 1.099854
| 11.298828
| 137
| 7.229492
| 135
| 72
| 375
| null | null |
no(M2 and SIP pres)
| 2.303711
| 919
| 0
|
95.05298
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 0
| 20,485
| 7,978.0625
| 15,630.6328
| 20
|
white
| 26.398438
| 41
| 0.588989
| 0.47998
| 3
| 0
| 0
|
no
| 0.05
| 0.05
|
no dnr
| 12
| 67
| 6.099609
| 80
| 25
| 36.09375
| 188
| null | null | 1.299805
| 142
| 7.349609
| 103
| 24
| 2,250
| 6
| 0
|
no(M2 and SIP pres)
| 0
| 873
| 1
|
89.84796
|
male
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 9
| 50,121
| 27,595.3594
| 34,923.2812
| 6
|
white
| 16.296875
| 24
| 0.767944
| 0.692993
| 6
| 1
| 1
|
no
| 0.2
| 0.1
|
dnr before sadm
| 0
| 59
| 22.097656
| 132
| 34
| 37.59375
| 142.84375
| 4.199219
| 0.399963
| 0.899902
| 137
| 7.399414
| 153
| 10
| 1,450
| null | null | null | 5.825195
| 918
| 0
|
20.821
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$25-$50k
| 0
| 92,095
| 73,341.125
| 32,757.2656
| 26.333328
|
white
| 20.796875
| 38
| 0.922974
| 0.894897
| 3
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 19
| 73
| 4.899414
| 70
| 25
| 36.09375
| 390.4375
| null | null | 1.5
| 141
| 7.5
| 103
| 35
| 800
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 917
| 0
|
76.91699
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 5
|
$11-$25k
| 9
| 10,552
| 4,853.0273
| 7,077.19922
| 7.5
|
black
| 20.097656
| 60
| 0.799927
| 0.733887
| 1
| 1
| 1
|
no
| 0.1
| 0
|
dnr after sadm
| 2
| 113
| 6.299805
| 43
| 12
| 36.19531
| 105
| null | 3.299805
| 0.699951
| 144
| 7.5
| 145
| 14
| 3,660
| null | 6
|
<2 mo. follow-up
| 6
| 8
| 1
|
85.336
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 9
| 12,972
| 7,308.043
| 6,891.02734
| 18.5
|
white
| 18.5
| 22
| 0.744995
| 0.5979
| 1
| 0
| 0
|
no
| null | null |
dnr before sadm
| -1
| 73
| 15.599609
| 135
| 28
| 40.19531
| 230
| 2.099609
| 0.399963
| 0.5
| 158
| 7.379883
| 148
| 3.299805
| 1,870
| null | 3
|
adl>=4 (>=5 if sur)
| 3
| 110
| 1
|
87.75397
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null |
under $11k
| 0
| 53,522
| 34,284.5938
| 32,349.7969
| 49
|
white
| 31.898438
| 63
| 0.359985
| 0.241974
| 7
| 0
| 0
|
yes
| 0.1
| 0.05
|
dnr after sadm
| 1
| 76
| 20.796875
| 70
| 28
| 36.09375
| null | 3
| null | 1.099854
| 141
| null | 116
| 21
| null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
70.28894
|
male
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 4
| null | null | 0
| 24,749
| 13,033.4609
| 11,678.7031
| 59
|
white
| 57.195313
| 91
| 0.001
| 0
| 1
| 1
| 0
|
metastatic
| null | null |
dnr after sadm
| 2
| 122
| 13.599609
| 71
| 24
| 38.19531
| 144.875
| null | null | 0.699951
| 141
| 7.509766
| 116
| 32
| 3,066
| null | null |
<2 mo. follow-up
| 2.754883
| 3
| 1
|
60.40198
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 11
|
under $11k
| 0
| 5,828
| 3,155.9629
| 3,686.91992
| 12
|
black
| 15.298828
| 18
| 0.918945
| 0.862915
| 1
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 5
| 50
| 12.199219
| 61
| 28
| 38.09375
| 143.3125
| 2.599609
| 1.899902
| 1
| 138
| 7.439453
| 112
| 9
| 5,625
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 912
| 0
|
74.11597
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 44
| 55,886
| 33,183.25
| 38,731.0312
| 39
|
white
| 18.097656
| 31
| 0.649902
| 0.550903
| 3
| 0
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 10
| 62
| 8.699219
| 64
| 12
| 37.79688
| 376.1875
| 1.799805
| 11.699219
| 1.599854
| 138
| 7.399414
| 98
| 37
| null | null | null |
<2 mo. follow-up
| 3.237793
| 11
| 1
|
87.633
|
male
| 0
| 34
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 56,611
| 29,262.4375
| 27,387.3281
| 13.25
|
white
| 15.5
| 20
| 0.698975
| 0.534912
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 34
| 83
| 3.5
| 80
| 30
| 37
| null | 4.599609
| 0.399963
| 0.899902
| 138
| null | 91
| 9
| 4,900
| null | 2
|
SIP>=30
| 2
| 181
| 1
|
83.08295
|
female
| 1
| 4
|
Coma
|
Coma
| 2
| 12
|
under $11k
| 0
| 5,078
| 1,799.9971
| 4,726.70703
| 8
|
white
| 14.798828
| 22
| 0.685913
| 0.629883
| 1
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 1
| 34
| 18.398438
| 41
| 8
| 35.39844
| 238
| null | null | 2.399902
| 137
| 7.399414
| 292
| 27
| 340
| null | 1
|
<2 mo. follow-up
| 1
| 4
| 1
|
78.63898
|
female
| 0
| 14
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 23,239
| 11,915.2344
| 16,760.0312
| 10
|
white
| 7.299805
| 25
| 0.836914
| 0.642944
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.4
|
dnr after sadm
| 1
| 70
| 5.399414
| 80
| 25
| 36.09375
| 233.3125
| 3.699707
| 0.599976
| 6.699219
| 139
| 7.319336
| 201
| 83
| 3,105
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 140
| 1
|
91.92297
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 27,153
| 7,410.3867
| 22,544.9375
| 40.5
|
white
| 28.699219
| 32
| 0.590942
| 0.481995
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 141
| 22.097656
| 123
| 34
| 38
| 155
| 3.299805
| 0.599976
| 0.799927
| 141
| 7.5
| 172
| 13
| 1,730
| null | 2
|
<2 mo. follow-up
| 2
| 11
| 1
|
79.01196
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 18,246
| 13,885.0781
| 13,115.5078
| 20.5
|
white
| 19.898438
| 34
| 0.773926
| 0.700928
| 1
| 0
| 0
|
yes
| 1
| 1
|
no dnr
| 9
| 63
| 8.298828
| 80
| 30
| 37.79688
| 257.125
| 2.199707
| null | 3.899902
| 142
| 7.339844
| 207
| 116
| 1,720
| 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 337
| 1
|
31.82999
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 15
|
under $11k
| 0
| 8,811
| 5,220.5625
| 3,264.34961
| 20
|
white
| 21
| 30
| 0.924927
| 0.872925
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 6
| 115
| 14
| 120
| 28
| 38.29688
| null | null | null | 6.299805
| 138
| null | 102
| 83
| 3,330
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 394
| 1
|
66.06995
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 9
| null | 0
| 9,945
| 6,046.1016
| 8,137.56641
| 13
|
white
| 25.597656
| 16
| 0.494995
| 0.174988
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.4
|
no dnr
| 6
| 76
| 5.899414
| 80
| 24
| 36.69531
| null | 3.399902
| 2
| 1
| 143
| null | 110
| 15
| 410
| 2
| 0
| null | 0
| 62
| 1
|
68.75299
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| null | null | null | 39
|
white
| 37.398438
| 74
| 0.379944
| 0.261963
| 22
| 0
| 0
|
no
| 0.1
| 0.1
|
no dnr
| 8
| 110
| 7.699219
| 120
| 34
| 37.79688
| 224
| 1.899902
| 0.699951
| 0.5
| 135
| 7.449219
| 137
| 5
| 3,565
| null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
91.81696
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 9
| 13,455
| 5,766.6562
| 10,643.75
| 13.5
|
white
| 20.597656
| 37
| 0.714966
| 0.628906
| 2
| 1
| 1
|
no
| 0.85
| 0.5
|
dnr after sadm
| 3
| 68
| 11.599609
| 70
| 28
| 37.69531
| 342.8125
| 3.599609
| 1.099854
| 13.099609
| 152
| 7.439453
| 151
| 178
| 241
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 315
| 1
|
71.59796
|
female
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 36,646
| 14,415.6328
| 23,589.1562
| 19
|
black
| 21.097656
| 40
| 0.817993
| 0.704956
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 18
| 67
| 20.199219
| 100
| 40
| 38.29688
| null | null | 0.5
| 1
| 139
| null | 161
| 14
| null | 1
| 3
|
no(M2 and SIP pres)
| 3
| 532
| 1
|
40.60199
|
male
| 0
| 11
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 6
| 12
|
under $11k
| 0
| 11,743
| 6,783.0039
| 6,489.71875
| 8.5
|
black
| 18.699219
| 18
| 0.887939
| 0.813965
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
dnr after sadm
| 5
| 60
| 8.699219
| 120
| 14
| 34.29688
| 158
| 1.799805
| null | 1.699951
| 132
| 7.40918
| 215
| 50
| 2,535
| null | null |
SIP>=30
| 3.787598
| 904
| 0
|
55.85199
|
female
| 0
| 110
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 340,910
| 190,980.5
| 237,194.25
| 32.75
|
white
| 19
| 34
| 0.887939
| 0.8479
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 110
| 33
| 0.5
| 150
| 12
| 38.69531
| 60
| 4.199219
| 1.199951
| 1.699951
| 140
| 7.319336
| 159
| 22
| 450
| null | null |
no(M2 and SIP pres)
| 1.932861
| 903
| 0
|
64.51495
|
male
| 0
| 11
|
Lung Cancer
|
Cancer
| 3
| null | null | 0
| 14,429
| 8,822.6641
| 8,022.30859
| 11
|
white
| 15
| 13
| 0.747925
| 0.485962
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 11
| 113
| 7.5
| 70
| 25
| 36.69531
| 280.9375
| null | null | 1
| 141
| 7.369141
| 153
| 19
| null | null | null | null | 3.121094
| 901
| 0
|
67.409
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
| null | 0
| 49,973
| null | null | 25.5
|
white
| 19.5
| 26
| 0.780884
| 0.708984
| 6
| 1
| 0
|
yes
| 0.8
| 0.8
|
no dnr
| 13
| 68
| 9.398438
| 74
| 8
| 38.09375
| 145
| 2.099609
| null | 1.299805
| 144
| 7.5
| 123
| 30
| 3,263
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 900
| 0
|
77.74695
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 3,228
| 1,775.8408
| 1,782.64941
| 11
|
white
| 19.898438
| 28
| 0.822998
| 0.711914
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 4
| 80
| 16.699219
| 80
| 20
| 36.09375
| 261.875
| 3.899902
| 0.799927
| 1.5
| 140
| 7.339844
| 80
| 35
| null | null | null |
no(M2 and SIP pres)
| 2.09668
| 898
| 0
|
85.91895
|
female
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 16
|
>$50k
| 0
| 16,137
| 9,039.2656
| 8,929.63281
| 6
|
white
| 21.898438
| 36
| 0.759888
| 0.618896
| 1
| 1
| 1
|
no
| 0.7
| 0.5
|
dnr after sadm
| 2
| 103
| 9.599609
| 80
| 20
| 38.89844
| 402
| null | null | 1.5
| 137
| 7.439453
| 170
| 25
| 1,885
| null | 3
|
adl>=4 (>=5 if sur)
| 3
| 133
| 1
|
40.17499
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 9,842
| 4,744.2148
| 7,251.03906
| 14
|
white
| 15.798828
| 6
| 0.93396
| 0.909912
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 6
| 76
| 5.099609
| 64
| 12
| 36.39844
| null | 4.299805
| 0.299988
| 1.099854
| 137
| null | 93
| 23
| null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 898
| 0
|
78.448
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 19,295
| 9,187.2734
| 8,324.23438
| 21.5
|
white
| 16.097656
| 34
| 0.863892
| 0.815918
| 1
| 1
| 0
|
no
| 0.6
| 0.4
|
no dnr
| 10
| 49
| 13.099609
| 117
| 8
| 38.29688
| 198
| 2.5
| 0.799927
| 0.799927
| 134
| 7.429688
| 93
| 11
| 2,277
| null | null |
SIP>=30
| 2.557617
| 315
| 1
|
85.55798
|
female
| 1
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 12,845
| 4,185.3398
| 8,544.5
| 36
|
white
| 36.09375
| 51
| 0.246979
| 0.08699
| 1
| 1
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 3
| 113
| 15.699219
| 70
| 14
| 39.09375
| 409.5
| null | null | 2.099609
| 136
| 7.399414
| 281
| 38
| 1,270
| null | 6
|
<2 mo. follow-up
| 6
| 5
| 1
|
86.89398
|
female
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
| null | 44
| 50,008
| 25,600.2812
| 28,714.0781
| 18.75
|
white
| 17.097656
| 36
| 0.658936
| 0.560913
| 4
| 1
| 0
|
no
| null | null |
dnr after sadm
| 8
| 80
| 10.298828
| 110
| 30
| 36.09375
| 237.5
| 3.799805
| 1.099854
| 1.399902
| 135
| 7.449219
| 87
| 24
| 1,879
| null | null |
adl>=4 (>=5 if sur)
| 4.15332
| 404
| 1
|
67.26099
|
male
| 1
| 7
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 17,966
| 9,470.0312
| 8,934.44531
| 22
|
white
| 40.398438
| 77
| 0.093994
| 0.003
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 5
| 100
| 24.699219
| 80
| 25
| 36.09375
| 436
| 3.199707
| null | 1
| 129
| 7.429688
| 124
| 14
| null | null | null |
<2 mo. follow-up
| 2.729492
| 7
| 1
|
68.94696
|
male
| 0
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 8
|
$11-$25k
| 0
| 16,339
| 8,028.6094
| 11,330.0234
| 16
|
black
| 28.898438
| 42
| 0.497986
| 0.380981
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 7
| 70
| 12.199219
| 120
| 10
| 36.29688
| 96.25
| 2.299805
| 0.799927
| 4.899414
| 132
| 7.219727
| 103
| 50
| 0
| 7
| 4
|
no(M2 and SIP pres)
| 4
| 133
| 1
|
74.92999
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 7
| null | 0
| 6,121
| 3,628.7383
| 5,463.69922
| 5
|
white
| 21.597656
| 18
| 0.576904
| 0.255981
| 1
| 0
| 0
|
metastatic
| null | 0.1
|
no dnr
| 4
| 65
| 10.599609
| 56
| 30
| 38.69531
| 183.65625
| 2.399902
| null | 1.099854
| 135
| 7.389648
| 306
| 28
| 1,350
| 0
| 3
|
<2 mo. follow-up
| 3
| 48
| 1
|
85.99298
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 10,742
| 4,711.6367
| 6,813.66797
| 14.5
|
white
| 26.097656
| 34
| 0.682983
| 0.588989
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 2
| 67
| 13.5
| 60
| 6
| 38.79688
| 136.65625
| 4.099609
| 0.799927
| 2
| 142
| 7.419922
| 157
| 24
| 645
| null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
87.82196
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
| null | 0
| 32,606
| 13,760.4141
| 24,916.1562
| 31
|
white
| 41
| 55
| 0.17099
| 0.085999
| 10
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 3
| 83
| 3.899902
| 80
| 20
| 36.09375
| null | 1.5
| 1.699951
| 0.899902
| 129
| null | 125
| 11
| null | null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
88.53699
|
female
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 100
| 26,190
| 17,459.5625
| 17,609.0781
| 17
|
white
| 23.898438
| 35
| 0.237
| 0.080994
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 10
| 110
| 8.5
| 110
| 14
| 38.39844
| 314
| 2.799805
| 0.399963
| 0.5
| 150
| 7.339844
| 300
| 25
| 1,335
| 1
| 4
| null | 4
| 82
| 1
|
63.064
|
female
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 4,934
| 2,945.0371
| 3,347.66992
| 9
|
white
| 22.597656
| 27
| 0.844971
| 0.745972
| 1
| 0
| 0
|
no
| 1
| 0.98
|
no dnr
| 5
| 80
| 6.099609
| 100
| 20
| 37.39844
| null | null | 0.399963
| 1
| 136
| null | 111
| 10
| 600
| 2
| null |
no(M2 and SIP pres)
| 1.838867
| 865
| 1
|
71.15094
|
female
| 0
| 100
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 179,736
| 94,621.375
| 113,885.5
| 22.75
|
white
| 21.699219
| 38
| 0.758911
| 0.681885
| 15
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 100
| 105
| 9.898438
| 102
| 24
| 38.5
| 171.40625
| 2.599609
| 1.199951
| 1.199951
| 137
| 7.5
| 200
| 24
| 3,400
| null | null |
adl>=4 (>=5 if sur)
| 3.098145
| 833
| 1
|
41.16098
|
female
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 21,183
| 8,702.5938
| 12,183.8672
| 17
|
white
| 31.898438
| 53
| 0.464966
| 0.345947
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 3
| 73
| 9.599609
| 60
| 20
| 36.09375
| 358.3125
| null | null | 1.799805
| 137
| 7.349609
| 222
| 30
| 1,850
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 214
| 1
|
45.43198
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 123,970
| 67,890.6875
| 71,768.625
| 25.333328
|
black
| 32.5
| 42
| 0.677979
| 0.582886
| 10
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 23
| 100
| 15.099609
| 80
| 20
| 38.29688
| 626.625
| null | 0.599976
| 3.899902
| 132
| 7.359375
| 277
| 86
| 950
| null | null | null | 2.731934
| 886
| 0
|
91.13794
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null |
under $11k
| 9
| 5,236
| 2,960.1621
| 3,021.78906
| 7
|
white
| 17
| 18
| 0.789917
| 0.661987
| 1
| 0
| 1
|
no
| 0.4
| 0.2
|
dnr before sadm
| -1
| 117
| 5.599609
| 72
| 20
| 38.19531
| 218.3125
| 3.699707
| 0.399963
| 0.899902
| 133
| 7.349609
| 85
| 10
| 2,100
| null | null | null | 6.092773
| 407
| 1
|
81.13599
|
female
| 0
| 36
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 38,685
| 22,244.0469
| 21,736
| 7.5
|
white
| 14.398438
| 24
| 0.841919
| 0.740967
| 1
| 0
| 0
|
yes
| 0.8
| 0.7
|
dnr after sadm
| 2
| 60
| 9.798828
| 62
| 24
| 38.39844
| 480
| 2.699707
| 1.799805
| 1.199951
| 149
| 7.449219
| 719
| 63
| 700
| 1
| 0
| null | 0
| 885
| 0
|
58.349
|
female
| 0
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 12,365
| 5,889.5469
| 10,857.9688
| 14.5
|
white
| 18.796875
| 9
| 0.748901
| 0.669922
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 11
| 53
| 8.898438
| 96
| 33
| 35.79688
| 136.71875
| 2.599609
| 1.599854
| 1.899902
| 138
| 7.419922
| 187
| 41
| 1,855
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 158
| 1
|
90.48596
|
female
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 14,422
| 5,378.875
| 11,185.9844
| 20.5
|
white
| 26.898438
| 46
| 0.642944
| 0.541992
| 1
| 0
| 0
|
no
| null | null |
dnr before sadm
| -1
| 133
| 9.298828
| 82
| 24
| 36.79688
| 432
| null | 0.5
| 1.799805
| 147
| 7.379883
| 247
| 29
| 1,435
| null | 3
|
<2 mo. follow-up
| 3
| 9
| 1
|
45.95798
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
>$50k
| 0
| 31,723
| 21,983.0938
| 24,126.875
| 23.666656
|
white
| 21.097656
| 31
| 0.861938
| 0.813965
| 1
| 0
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 15
| 111
| 0.099991
| 140
| 28
| 36.29688
| 380
| 2
| 0.799927
| 3.5
| 142
| 7.359375
| 235
| 69
| 2,250
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 882
| 0
|
78.58698
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 0
| 31,302
| 15,784.8203
| 10,890.2734
| 24.666656
|
white
| 38.5
| 68
| 0.406982
| 0.286987
| 1
| 1
| 1
|
no
| 0.8
| 0.5
|
dnr before sadm
| -1
| 80
| 2.299805
| 68
| 16
| 36.09375
| 556
| 2.299805
| 2.399902
| 2
| 154
| 7.459961
| 90
| 33
| 1,920
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 879
| 0
|
53.12799
|
female
| 0
| 45
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 44
| 92,751
| 57,897
| 61,964.25
| 15
|
black
| 23.199219
| 38
| 0.670898
| 0.574951
| 10
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 45
| 76
| 11.798828
| 72
| 16
| 36.5
| null | 3.099609
| 0.399963
| 1.099854
| 138
| null | 127
| 22
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 879
| 0
|
82.04797
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 6
|
under $11k
| 0
| 16,409
| 12,120.5391
| 12,838.2734
| 30.5
|
white
| 28.699219
| 39
| 0.570923
| 0.376953
| 1
| 0
| 0
|
yes
| 0.85
| 0.85
|
no dnr
| 9
| 107
| 18.199219
| 68
| 30
| 36.69531
| null | 3.099609
| 1.099854
| 3.699707
| 150
| null | 179
| 99
| 2,003
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 879
| 0
|
47.95297
|
female
| 1
| 7
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 12,930
| 6,180.0547
| 6,376.09766
| 20
|
black
| 17.5
| 17
| 0.736938
| 0.469971
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.1
|
dnr after sadm
| 2
| 51
| 7.099609
| 50
| 6
| 35.59375
| 74
| null | null | 3
| 135
| 7.339844
| 72
| 105
| 1,024
| 0
| 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
73.758
|
female
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
under $11k
| 0
| 46,212
| 15,088.2344
| 33,754.7812
| 25
|
white
| 25.5
| 40
| 0.62793
| 0.523926
| 7
| 0
| 0
|
yes
| 0.6
| 0.6
|
dnr after sadm
| 8
| 61
| 11.199219
| 62
| 24
| 38.29688
| 120
| 3.799805
| null | 2.299805
| 138
| 7.419922
| 142
| 43
| 1,072
| null | 1
|
no(M2 and SIP pres)
| 1
| 877
| 0
|
88.23297
|
female
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 8,650
| 3,403.5019
| 6,157.62891
| 19
|
white
| 23.097656
| 22
| 0.73291
| 0.649902
| 1
| 0
| 0
|
no
| 1
| 0.95
|
no dnr
| 5
| 83
| 11.398438
| 100
| 25
| 36.09375
| null | null | null | 1.599854
| 135
| null | 97
| 47
| 2,100
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 877
| 0
|
61.74899
|
male
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
$25-$50k
| 0
| 13,353
| 6,758.6875
| 7,565.27734
| 20
|
white
| 28.097656
| 54
| 0.45697
| 0.337952
| 6
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 73
| 12.898438
| 100
| 24
| 37.39844
| 363.25
| 2.399902
| null | 2.099609
| 135
| 7.389648
| 234
| 37
| 1,145
| null | null |
<2 mo. follow-up
| 2.373047
| 3
| 1
|
88.00299
|
female
| 0
| 76
|
Coma
|
Coma
| 1
| 14
|
under $11k
| 44
| 102,276
| 55,993.5
| 18,285.5156
| 20.5
|
white
| 13.699219
| 17
| 0.555908
| 0.487976
| 1
| 0
| 1
|
no
| 0.5
| 0.3
|
dnr after sadm
| 27
| 57
| 0.799927
| 128
| 36
| 39.39844
| 328
| 2.599609
| 0.599976
| 0.799927
| 136
| 7.489258
| 112
| 10
| 2,100
| null | 1
| null | 1
| 89
| 1
|
76.92798
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 14,385
| 6,852.5547
| 8,700.625
| 4.5
|
white
| 22.296875
| 35
| 0.552979
| 0.22998
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 7
| 50
| 21
| 110
| 8
| 38.19531
| 195
| null | null | 2.899902
| 141
| 7.40918
| 68
| 17
| 2,100
| null | null |
no(M2 and SIP pres)
| 2.375
| 135
| 1
|
67.31299
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 11
|
under $11k
| 9
| 13,149
| 5,712.6484
| 9,494.33594
| 15.5
|
white
| 14.298828
| 29
| 0.893921
| 0.821899
| 1
| 0
| 0
|
no
| 0.8
| 0.65
|
no dnr
| 9
| 67
| 8.099609
| 60
| 15
| 36.09375
| 403.3125
| null | null | 1.299805
| 139
| 7.359375
| 119
| 21
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 590
| 1
|
76.14197
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 7,858
| 4,060.5547
| 4,837.07812
| 7
|
white
| 15.5
| 18
| 0.861938
| 0.771973
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 6
| 70
| 16.398438
| 80
| 30
| 37
| null | 4
| 0.899902
| 0.899902
| 134
| null | 111
| 8
| 1,050
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 875
| 0
|
66.63898
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 7,222
| 3,841.3008
| 1,428.11914
| 7
|
black
| 12
| 13
| 0.922974
| 0.868896
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 6
| 71
| 3.699707
| 74
| 20
| 38.09375
| 419
| null | null | 0.599976
| 139
| 7.449219
| 101
| 3
| 3,900
| 0
| 0
| null | 0
| 163
| 1
|
79.50696
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
|
$11-$25k
| 0
| 4,092
| 2,277.5312
| 1,371.8291
| 8
|
white
| 20.898438
| 36
| 0.80188
| 0.679932
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 52
| 13.599609
| 107
| 24
| 37.79688
| 230.59375
| 3.399902
| null | 2
| 141
| 7.40918
| 388
| 52
| 1,780
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 207
| 1
|
44.06299
|
male
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
$11-$25k
| 0
| 106,706
| 53,907.25
| 59,940.9688
| 25.5
|
black
| 37.09375
| 43
| 0.261963
| 0.155975
| 27
| 0
| 0
|
yes
| 0.75
| 0.5
|
no dnr
| 10
| 56
| 7.399414
| 117
| 8
| 38.09375
| 442.5
| null | null | 1
| 138
| 7.439453
| 97
| 12
| 2,111
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 193
| 1
|
54.56497
|
female
| 1
| 27
|
Coma
|
Coma
| 3
| 13
|
>$50k
| 0
| 90,807
| 75,018.625
| 77,704.5
| 42
|
white
| 28.699219
| 48
| 0.598999
| 0.534912
| 6
| 0
| 0
|
no
| 0.01
| 0.01
|
no dnr
| 27
| 49
| 15.599609
| 70
| 24
| 40.09375
| 120
| 3.099609
| 0.5
| 2.799805
| 156
| 7.199219
| 355
| 85
| 1,980
| null | 0
|
<2 mo. follow-up
| 0
| 27
| 1
|
70.49097
|
male
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 11
| null | 0
| 129,379
| 49,179.8125
| 84,771.6875
| 36.25
|
white
| 24.796875
| 31
| 0.73291
| 0.649902
| 5
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 37
| 113
| 21.796875
| 120
| 34
| 38.79688
| 293.875
| null | null | 0.799927
| 148
| 7.519531
| 150
| 10
| 1,265
| null | 0
|
no(M2 and SIP pres)
| 0
| 873
| 0
|
50.12997
|
male
| 0
| 32
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
| null | 0
| 103,700
| 53,768.3438
| 50,489
| 28.5
|
other
| 35.09375
| 48
| 0.33197
| 0.21698
| 12
| 0
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 32
| 45
| 10.699219
| 75
| 14
| 38
| 363.3125
| null | 1.299805
| 2.699707
| 141
| 7.619141
| 173
| 47
| 3,105
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 272
| 1
|
76.85699
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
$11-$25k
| 0
| 26,843
| 12,188.6875
| 17,197.6719
| 11.333328
|
white
| 20.898438
| 20
| 0.786987
| 0.717896
| 3
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 16
| 69
| 11.798828
| 100
| 24
| 36.59375
| null | 3.599609
| 0.699951
| 0.699951
| 137
| null | 129
| 7
| 1,800
| 1
| 0
|
SIP>=30
| 0
| 456
| 1
|
67.42499
|
female
| 0
| 15
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 20,324
| 11,267.1641
| 14,598.3672
| 14
|
white
| 22.199219
| 12
| 0.728882
| 0.45697
| 1
| 0
| 0
|
metastatic
| 0.93
| 0.7
|
no dnr
| 15
| 53
| 10.298828
| 113
| 14
| 38.29688
| 166.65625
| 2.099609
| null | 0.899902
| 138
| 7.379883
| 140
| 18
| 2,130
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 252
| 1
|
76.19696
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
| null | 0
| 18,925
| 10,816.7031
| 11,470.0391
| 15.5
|
white
| 20.296875
| 64
| 0.762939
| 0.68689
| 2
| 0
| 0
|
yes
| 0.9
| 0.5
|
no dnr
| 8
| 127
| 15.298828
| 49
| 29
| 36.09375
| 286.625
| 3.599609
| 1.399902
| 0.799927
| 137
| 7.40918
| 136
| 15
| 2,210
| 5
| null |
adl>=4 (>=5 if sur)
| 3.854981
| 95
| 1
|
63.81699
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 16
|
under $11k
| 0
| 18,628
| 9,706.6719
| 11,663.5625
| 7
|
white
| 21.699219
| 26
| 0.851929
| 0.755981
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
dnr before sadm
| -1
| 50
| 29.199219
| 110
| 32
| 36.59375
| 270
| 2.299805
| null | 1
| 145
| 7.289062
| 122
| 30
| 995
| null | 3
|
SIP>=30
| 3
| 869
| 0
|
76.01398
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 8
|
under $11k
| 0
| 8,725
| 4,444.0039
| 5,004.77734
| 19
|
white
| 21.796875
| 20
| 0.780884
| 0.649902
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
dnr before sadm
| 0
| 67
| 7.5
| 70
| 20
| 38.39844
| 663.25
| null | null | 0.699951
| 141
| 7.469727
| 89
| 16
| 750
| 4
| 5
|
SIP>=30
| 5
| 123
| 1
|
67.63898
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 18
| null | 0
| 17,103
| 8,721.7734
| 9,222.77344
| 13.5
|
white
| 17.898438
| 22
| 0.873901
| 0.790894
| 1
| 0
| 0
|
no
| 0.99
| 0.97
|
no dnr
| 11
| 70
| 12
| 80
| 25
| 36.69531
| null | null | null | 2.799805
| 137
| null | 104
| 66
| null | 1
| null |
no(M2 and SIP pres)
| 1.166748
| 868
| 0
|
44.58298
|
female
| 0
| 24
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 39,887
| 14,321.3672
| 30,776.1094
| 29.333328
|
black
| 29.296875
| 44
| 0.85791
| 0.765991
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 24
| 71
| 16.699219
| 80
| 30
| 38.09375
| 260
| 3.799805
| 1.099854
| 1.299805
| 137
| 7.289062
| 166
| 26
| 3,500
| null | null |
no(M2 and SIP pres)
| 2.935059
| 122
| 1
|
73.42896
|
female
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 103,441
| 55,695.25
| 64,998.5
| 51
|
white
| 21.5
| 29
| 0.756958
| 0.679932
| 12
| 1
| 0
|
no
| 0.4
| 0.1
|
dnr after sadm
| 3
| 87
| 18.5
| 80
| 20
| 36.69531
| 488.3125
| null | null | 1.099854
| 138
| 7.359375
| 137
| 26
| 600
| null | null |
<2 mo. follow-up
| 2.218262
| 11
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.